NCT03316573 2026-02-10Pembrolizumab in Neoplasms or LymphomasDana-Farber Cancer InstitutePhase 2 Suspended18 enrolled 16 charts
NCT03651375 2021-01-22UN-RESARCMaria Sklodowska-Curie National Research Institute of OncologyPhase 2 Unknown46 enrolled